Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China.
Authors: Gao Y, Lv N, Diao R
Journal: Human vaccines & immunotherapeutics
group therapy
mental health
open access